PAF Launches Copayment Assistance for Cervical Cancer

Tuesday, August 26, 2014

HAMPTON, VA– Patient Advocate Foundation (PAF) launched a new copayment assistance fund for patients with cervical cancer within its Co-Pay Relief (CPR) program on August 22, 2014.  As the only copayment program in the country geared specifically towards the needs of cervical cancer patients, this fund will provide direct financial support for pharmaceutical expenses related to the treatment and management of the disease for insured patients. Approved patients are eligible for up to $4,000 in available assistance per award year, providing an unprecedented level of relief from the financial hardships faced by women battling the disease.

“When treatment protocols are recommended by physicians, a patient’s survival can be jeopardized if they are unable to access the prescribed pharmaceuticals in an expedient manner. This financial assistance will ensure that practical barriers do not pose a delay for cervical cancer patients, thus improving access to necessary treatments for women suffering with cervical cancer,” stated Alan Balch, CEO of PAF.

“The launch of this silo represents a tremendous advance in reducing the access challenges of cervical cancer patients, and we are tremendously grateful for the generous donation that has made this support available through our Co-Pay Relief Program,” said Beth Moore, Executive Vice President of Program Strategy for PAF.

Martha Petit of Peninsula Cancer Institute (PCI) and Riverside Cancer Infusion Center commented on the launch saying “gynecologic cancers are greatly underserved as far as available financial resources. So many cervical cancer patients have expressed their struggle meeting the financial obligations of their pharmaceutical therapy and medications, and unfortunately there have been very few programs available. These are difficult diagnoses and many women need to continue treatment for extended periods of time increasing the emotional and medical debt to devastating levels.”  Petit continued stating “this program is a monumental leap in support available for women affected by cervical cancer. BRAVO to Patient Advocate Foundation for stepping up by helping these women to have a much improved quality of life.”

Since PAF’s Co-Pay Relief program was founded in 2004, it has provided more than $190 million in financial assistance to more than 95,000 patients who would have been otherwise unable to afford their pharmaceutical co-payments. The program provides this support to insured patients who financially and medically qualify. Approved cervical cancer patients may receive up to $4,000 in assistance per year for copayment needs directly related to their pharmaceutical therapies.

For detailed eligibility guidelines on this program or to initiate an application for assistance within PAF’s Co-Pay Relief program, visit or call 866-512-3861.